Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy
Open Access
- 19 November 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 13 (12), 1285-1295
- https://doi.org/10.1634/theoncologist.2008-0130
Abstract
Learning Objectives: After completing this course, the reader should be able to: Assess the common symptoms of central nervous system toxicity seen in patients treated with chemotherapy and cranial radiation.Diagnose the patterns of cognitive dysfunction encountered in patients treated for cancer.Evaluate cranial imaging abnormalities consistent with nervous system toxicity from cancer therapy.Explain the novel concepts of the cell-biological consequences underlying chemotherapy- and radiation therapy–associated nervous system toxicity. CME This article is available for continuing medical education credit at CME.TheOncologist.com Standard oncological therapies, such as chemotherapy and cranial radiotherapy, frequently result in a spectrum of neurocognitive deficits that includes impaired learning, memory, attention, and speed of information processing. In addition to classical mechanisms of neurotoxicity associated with chemo- and radiotherapy, such as radiation necrosis and leukoencephalopathy, damage to dynamic progenitor cell populations in the brain is emerging as an important etiologic factor. Radiation- and chemotherapy-induced damage to progenitor populations responsible for maintenance of white matter integrity and adult hippocampal neurogenesis is now believed to play a major role in the neurocognitive impairment many cancer survivors experience.Keywords
This publication has 96 references indexed in Scilit:
- Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous systemJournal of Biology, 2008
- Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapyBreast Cancer Research and Treatment, 2006
- Cancer as a Risk Factor for Long-Term Cognitive Deficits and DementiaJNCI Journal of the National Cancer Institute, 2005
- Complications of Radiation Therapy on the Brain and Spinal CordSeminars in Neurology, 2004
- Phase II study of alpha‐tocopherol in improving the cognitive function of patients with temporal lobe radionecrosisCancer, 2004
- The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapyPsycho‐Oncology, 2003
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionCell, 2003
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- Pathogenesis of Irradiation-Induced Cognitive DysfunctionActa Oncologica, 1996
- Radiation‐induced dementia in patients cured of brain metastasesNeurology, 1989